| 1EPP |
IL-1-targeted epitope peptide vaccine adjuvant with polylactic acid microparticles |
| ADA |
American Diabetes Association |
| Alum |
Aluminum |
| APC |
Antigen presenting cells |
| BCG |
Bacillus Calmette–Guerin |
| CFA |
Complete Freund’s adjuvant |
| CTB |
Cholera toxin B subunit |
| DC |
Dendritic cell |
| DM |
Diabetes mellitus |
| DNA |
Deoxyribonucleic acid |
| DPP4 |
Dipeptidyl-peptidase-4-inhibitor |
| EV |
Enteroviruses |
| FDA |
Food and Drug Administration |
| GAD65 |
Glutamic acid decarboxylase 65-kD antibody |
| GFAP |
Glial fibrillary acidic protein |
| GLP |
Glucagon-like-peptide |
| IA-2 |
Insulinoma-associated protein 2 |
| IDF |
International Diabetes Federation |
| IFA |
Incomplete Freund’s adjuvant |
| INSB |
B chain of insulin |
| IL-1
|
Interleukin-1 cytokine |
| IL-10 |
Interleukin-10 |
| MHC |
Major histocompatibility complexes |
| MP |
Microparticle |
| NOD |
Non-obese diabetic |
| PRR |
Pattern recognition receptors |
| T1DM |
Type 1 diabetes mellitus |
| T2DM |
Type 2 diabetes mellitus |
| Th0 |
Naive helper T cell |
| Th1 |
Cytotoxic helper T cell |
| Th2 |
Humoral helper T cell |
| TLR |
Toll-like receptor |
| TNF |
Tumor necrosis factor |
| Treg cells |
Regulatory T cells |
| WHO |
World Health Organization |
| ZnT8 |
Zinc transporter isoform 8 |